83,383 Shares in Sotera Health Company $SHC Acquired by Rock Creek Group LLC

Rock Creek Group LLC purchased a new stake in Sotera Health Company (NASDAQ:SHC) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 83,383 shares of the company’s stock, valued at approximately $1,542,000.

Several other large investors have also modified their holdings of SHC. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Sotera Health in the 3rd quarter worth approximately $29,000. Meeder Asset Management Inc. acquired a new stake in shares of Sotera Health in the 2nd quarter valued at about $37,000. Provenance Wealth Advisors LLC purchased a new position in shares of Sotera Health during the third quarter worth approximately $42,000. Nykredit A S purchased a new position in Sotera Health during the 2nd quarter worth $50,000. Finally, IFP Advisors Inc increased its position in Sotera Health by 150.8% in the 2nd quarter. IFP Advisors Inc now owns 3,509 shares of the company’s stock valued at $62,000 after acquiring an additional 2,110 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Barclays cut their price objective on shares of Sotera Health from $22.00 to $20.00 and set an “overweight” rating for the company in a research report on Wednesday, November 4th. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price target on shares of Sotera Health in a research note on Tuesday, September 8th. Citigroup upped their target price on Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 7th. Finally, Weiss Ratings downgraded Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 23rd. Seven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $21.14.

Insider Buying and Selling at Sotera Health

In other news, Chairman Michael B. Jr. Petras sold 850,000 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the sale, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This represents a 17.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 15.36% of the company’s stock.

Sotera Health Stock Up 1.9%

Shares of NASDAQ:SHC traded up $0.31 during mid-day trading on Friday, hitting $16.61. 2,647,530 shares of the company traded hands, compared to its average volume of 2,660,564. Sotera Health Company has a 52-week low of $13.09 and a 52-week high of $19.85. The firm has a market cap of $4.74 billion, a P/E ratio of 27.68 and a beta of 1.94. The company has a debt-to-equity ratio of 3.04, a quick ratio of 2.91 and a current ratio of 3.13. The firm’s 50 day simple moving average is $17.96 and its 200 day simple moving average is $16.91.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.02. Sotera Health had a net margin of 14.11% and a return on equity of 38.46%. The company had revenue of $324.89 million during the quarter, compared to analysts’ expectations of $319.86 million. During the same period in the prior year, the company posted $0.26 EPS. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. On average, equities analysts anticipate that Sotera Health Company will post 0.89 EPS for the current year.

Sotera Health Profile

Sotera Health Company is a global provider of sterilization, laboratory testing and advisory services for the medical device, pharmaceutical and food industries. Its services help customers assess product safety, meet regulatory requirements and prepare products for use. Through Sterigenics, the company provides contract sterilization using technologies including ethylene oxide, gamma irradiation and electron beam processing. Nelson Labs offers microbiological and analytical testing, as well as consulting, for medical devices and pharmaceutical products.